Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ability to Learn How to Handle Inhaler Devices in COPD
NCT02813200Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jan 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol + fluticasone, indacaterol + glycopyrronium, tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Jan 2017; status: completed.
02
Drugs
salmeterol + fluticasoneindacaterol + glycopyrroniumtiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02813200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02813200.